In another study, nisin treatment in human colon cancer cell lines showcased the altered expression of CEA (Carcinoembryonic antigen) and matrix metalloproteinase (MMP) genes (Norouzi et al., 2018). The gene discussed is CEACAM5; the disease is malignant colon neoplasm.